Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesActive Biotechs Prostate Cancer Project TASQ Featured in British Journal of Cancer
Active Biotech, 09/28/09
British Journal of Cancer releases an article covering Active Biotech's prostate cancer project TASQ, where TASQ was studied as a single agent in patients with castration–resistant prostate cancer. Two open–label phase I clinical trials in patients with castration–resistant prostate cancer were conducted to evaluate the safety and tolerability of TASQ, with additional pharmacokinetic and efficacy assessments.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Sponsor
Article Search
Sponsor